Medcross taps into Asian market
Imaging services provider Medcrossis joining forces with Magnecel Services (MSI) to access the potentiallylucrative Asia-Pacific market. The two companies have formed ajoint venture firm, Medpacific, to sell and service Elscint medicalimaging equipment
Imaging services provider Medcrossis joining forces with Magnecel Services (MSI) to access the potentiallylucrative Asia-Pacific market. The two companies have formed ajoint venture firm, Medpacific, to sell and service Elscint medicalimaging equipment and linear accelerators.
The move is a logical step for the companies, both of whichare based in Florida. Medcross recently signed a joint ventureagreement with the Chinese Health Ministry to import CT scannersinto China, while third-party service provider Magnecel is theexclusive Florida sales and service organization for Elscint medicalimaging products.
Medcross is the majority shareholder in the venture.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.
